Sinopharm Group Co.-Unsp ADRSHTDY
13F holders, Q2 2025 (June 30)4holders +1
1new positions
0sold out
$11.67avg. 13F price*
At the end of Q2 2025, 4 institutions reported holding Sinopharm Group Co.-Unsp ADR (SHTDY) in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($13K), GAMMA Investing LLC ($2K) and PNC Financial Services Group, Inc. ($1K).
- Company
- Sinopharm Group Co.-Unsp ADR
- CUSIP
- 82937K101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $980 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 84 shares bought and 29 shares sold, net +55 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Rhumbline Advisers | 0.00% | No change | 1,101 | $13K |
| GAMMA Investing LLC | 0.00% | No change | 205 | $2K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -23.6% | 94 | $1K |
| First Horizon Advisors, Inc. | 0.00% | New | 84 | $980 |
"% of holder's portfolio" is SHTDY's weight in each manager's 13F, not the share of Sinopharm Group Co.-Unsp ADR the manager owns.